Kidney transplantation in the elderly: a decision analysis
ABSTRACT. Transplantation offers superior life expectancy and quality of life compared with
dialysis in young patients with end-stage renal failure. However, the initial risks of mortality …
dialysis in young patients with end-stage renal failure. However, the initial risks of mortality …
ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy
CE Stigant, J Cohen, M Vivera, JS Zaltzman - American journal of kidney …, 2000 - Elsevier
Angiotensin-converting enzyme inhibitors (ACEi) are a class of antihypertensive agents that
decrease mortality in congestive heart failure and have established efficacy in the treatment …
decrease mortality in congestive heart failure and have established efficacy in the treatment …
Outcomes of commercial renal transplantation: a Canadian experience
…, A Shukla, M Huang, RJDA Honey, JS Zaltzman - …, 2006 - journals.lww.com
Background. Financial compensation in exchange for live kidney donation is prohibited in
Canada. However, patients in Canada with end-stage renal disease and without a suitable …
Canada. However, patients in Canada with end-stage renal disease and without a suitable …
[HTML][HTML] Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins)
…, SJ Kim, M Huang, MM Nash, JS Zaltzman… - American Journal of …, 2004 - Elsevier
Statins have anti-inflammatory effects, modify endothelial function and improve peripheral
insulin resistance. We hypothesized that statins influence the development of new-onset …
insulin resistance. We hypothesized that statins influence the development of new-onset …
[HTML][HTML] Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation
…, MM Nash, L Rapi, M Huang, JS Zaltzman - BMC infectious …, 2019 - Springer
Background Trimethoprim-sulfamethoxazole (TMP-SMX) is the drug of choice for anti-Pneumocystis
jirovecii pneumonia (PcP) prophylaxis in kidney transplant recipients (KTR). Post-…
jirovecii pneumonia (PcP) prophylaxis in kidney transplant recipients (KTR). Post-…
Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk
F Bandukwala, M Huang, JS Zaltzman… - The American journal of …, 2009 - Elsevier
Hyperuricemia is common after kidney transplantation. Although its risk factors are well
established, its relation to inflammation, progressive renal dysfunction, and cardiovascular …
established, its relation to inflammation, progressive renal dysfunction, and cardiovascular …
Cyclosporine nephrotoxicity in lung transplant recipients
JS Zaltzman, Y Pei, J Maurer, A Patterson… - …, 1992 - journals.lww.com
End-stage lung disease has been treated successfully by lung transplantation (LTXP) at our
institution since 1983. We report on the renal function of 30 LTXP recipients who were …
institution since 1983. We report on the renal function of 30 LTXP recipients who were …
Efficacy OF azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients1, 2
MM Nash, JS Zaltzman - Transplantation, 1998 - journals.lww.com
Background. Gingival hyperplasia (GH) is a common side effect of cyclosporine. Azithromycin
(Zithromax; AZI) is a macrolide antibiotic reported in case studies to reduce cyclosporine-…
(Zithromax; AZI) is a macrolide antibiotic reported in case studies to reduce cyclosporine-…
Thrombotic microangiopathy in association with cytomegalovirus infection in a renal transplant patient: a new treatment strategy
FM Jeejeebhoy, JS Zaltzman - Transplantation, 1998 - journals.lww.com
Background. Cytomegalovirus (CMV) associated with thrombotic microangiopathy (TMA) in
transplant patients has not been extensively described. This case illustrates an association …
transplant patients has not been extensively described. This case illustrates an association …
Renal transplant recipient attitudes toward steroid use and steroid withdrawal
…, MM Nash, PA McFarlane, JS Zaltzman - Clinical …, 2003 - Wiley Online Library
Although steroid avoidance and withdrawal in renal transplant recipients (RTR) are actively
being evaluated by physicians, the attitudes of recipients toward steroid use have not been …
being evaluated by physicians, the attitudes of recipients toward steroid use have not been …
